Medical Alley Association, led by its Board of Directors and executives from all sectors of the Medical Alley healthcare community, convened two working groups to lead the development of a 10-year strategy plan for Minnesota to realize the vision of Medical Alley being recognized as the global epicenter of health innovation and care. Specifically, the two Working Groups focused on Minnesota Competitiveness and Early Stage Ecosystem.
“Minnesota’s place of leadership in the great history of healthcare advancement is secure. The goal of our Board and community is to ensure that Medical Alley continues to lead the transformation of healthcare around the world,” said Shaye Mandle, President & CEO, Medical Alley Association. “We’re excited to lay this foundation for the public and private sectors to work together to deliver the next generation of solutions and opportunities that define health innovation and care.” Mandle said.
The Medical Alley Working Groups have delivered a plan with specific recommendations and actions to address Minnesota’s competitive status, lead the development of the ideal early-stage ecosystem that can capitalize on the evolving health marketplace and position the state for a sustainable leadership position.
“Minnesota has a rich tradition of growing transformational healthcare companies and the talent to keep them innovating. Competing globally requires our elected officials to enact policies that encourage investment and growth, attract new talent, and properly prepares our workforce for the jobs this growth will create,” said Jeff Mirviss, Senior VP and President, Peripheral Interventions for Boston Scientific, and Co-Chair of the Minnesota State Competitiveness Working Group.
“Supporting startups and early-stage companies is critical to ensure that Minnesota remains the global epicenter of health innovation and care. This report puts forward solutions that require commitment and leadership from the public and private sectors. We look forward to working with our state’s leaders on moving these forward,” said Sheri Dodd, VP & GM, Medtronic Care Management Solutions & Non-Intensive Diabetes Therapies. Dodd also serves as the Co-Chair for the Early Stage Ecosystem Working Group.
Additional details can be found inside the plan, or by contacting the Medical Alley Association.
About the Medical Alley Association
Founded in 1984, the Medical Alley Association supports and advances the global leadership of Medical Alley’s healthcare industry, and its connectivity around the world. MAA delivers the collective influence, intelligence and interactions that support Medical Alley. www.medicalalley.org